UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Before investing in crypto, it's crucial to understand the market dynamics and risks involved. Equip yourself with knowledge for better decisions.
20,298 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Retail investors face shrinking net returns as private equity fees compress gains. A timely look at Jeff Hook’s blunt...
A 62-year-old facing five years before Social Security may need $800,000 to $1.14 million in investable assets to gen...
A high-profile hedge fund billionaire made bold moves, piling into Amazon and Microsoft while slashing a top AI stock...
As investors parse Nano-X Imaging's Q4 2025 results, this guide breaks down the numbers, the business model, and what...
A trio of municipal bond ETFs could deliver about $21,000 per year in federally tax-exempt income from a $500,000 sta...
Inflation is pushing up the price tag for Memorial Day cookouts, with beef and produce leading the gains. This report...
NVIDIA just raised dividend marks a bold shift in capital allocation as AI demand surges. This guide breaks down what...
Curious about riding the AI chip boom without placing a big bet on a single stock? This guide shows how ETFs can help...
A Deutsche Bank note over the weekend argued that the u.s. would only break an Iranian ceasefire if there was absolut...
Tuesday brought a notable rally in Honeywell shares as the company outlined a stand-alone path for Quantinuum. This a...
Alphabet's Gemini 3.5 showcases bold AI ambitions, but the stock is sliding as investors reassess ROI and token-based...